Mirati Therapeutics, Inc.
MRTXDelisted Jan 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001576263
Mirati Therapeutics, Inc. was delisted on Jan 23, 2024; its insiders filed their last Form 4 on Jan 25, 2024; 218 institutions reported holding it in 13F filings for Q4 2023, worth $4.66B in total; no superinvestor held it.
Politicians who traded MRTX
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 2
- Filings
- 2
- Politicians
- 1
- Buys / sells
- 1 / 1
- Estimated volume
- $16.0K
- Sum of range midpoints
| Politician | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
 Daniel S. Goldman House · NY | 2 | 1 / 1 | $16.0K | Apr 10, 2023 | May 19, 2023 |
Trades
Reported trades in Mirati Therapeutics, Inc., newest filings first.
| Politician | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
Daniel S. Goldman House · NY | MRTXMirati Therapeutics, Inc. | Sell | Self | Apr 10, 2023 | May 19, 2023 | 39 days | $1K-$15K | Filing |
Daniel S. Goldman House · NY | MRTXMirati Therapeutics, Inc. | Buy | Self | Mar 6, 2023 | Apr 17, 2023 | 42 days | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.